ID   PTN2_HUMAN              Reviewed;         415 AA.
AC   P17706; A8K955; A8MXU3; K7ENG3; Q96AU5; Q96HR2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   10-MAY-2017, entry version 186.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 2;
DE            EC=3.1.3.48;
DE   AltName: Full=T-cell protein-tyrosine phosphatase;
DE            Short=TCPTP;
GN   Name=PTPN2; Synonyms=PTPT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=T-cell;
RX   PubMed=2546150; DOI=10.1073/pnas.86.14.5257;
RA   Cool D., Tonks N.K., Charbonneau H., Walsh K.A., Fischer E.H.,
RA   Krebs E.G.;
RT   "cDNA isolated from a human T-cell library encodes a member of the
RT   protein-tyrosine-phosphatase family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:5257-5261(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 350-415 (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=1731319; DOI=10.1073/pnas.89.2.499;
RA   Mosinger B. Jr., Tillmann U., Westphal H., Tremblay M.L.;
RT   "Cloning and characterization of a mouse cDNA encoding a cytoplasmic
RT   protein-tyrosine-phosphatase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:499-503(1992).
RN   [8]
RP   SUBCELLULAR LOCATION (ISOFORMS 1 AND 2), AND MUTAGENESIS OF
RP   350-ARG--ARG-352 AND LYS-380.
RX   PubMed=7593185; DOI=10.1083/jcb.131.3.631;
RA   Lorenzen J.A., Dadabay C.Y., Fischer E.H.;
RT   "COOH-terminal sequence motifs target the T cell protein tyrosine
RT   phosphatase to the ER and nucleus.";
RL   J. Cell Biol. 131:631-643(1995).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=9361013; DOI=10.1074/jbc.272.46.29322;
RA   Hao L., Tiganis T., Tonks N.K., Charbonneau H.;
RT   "The noncatalytic C-terminal segment of the T cell protein tyrosine
RT   phosphatase regulates activity via an intramolecular mechanism.";
RL   J. Biol. Chem. 272:29322-29329(1997).
RN   [10]
RP   FUNCTION IN DEPHOSPHORYLATION OF EGFR AND SHC1, MUTAGENESIS OF
RP   ASP-182, AND SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=9488479; DOI=10.1128/MCB.18.3.1622;
RA   Tiganis T., Bennett A.M., Ravichandran K.S., Tonks N.K.;
RT   "Epidermal growth factor receptor and the adaptor protein p52Shc are
RT   specific substrates of T-cell protein tyrosine phosphatase.";
RL   Mol. Cell. Biol. 18:1622-1634(1998).
RN   [11]
RP   FUNCTION IN DEPHOSPHORYLATION OF INSR.
RX   PubMed=10734133; DOI=10.1074/jbc.275.13.9792;
RA   Waelchli S., Curchod M.L., Gobert R.P., Arkinstall S.,
RA   Hooft van Huijsduijnen R.;
RT   "Identification of tyrosine phosphatases that dephosphorylate the
RT   insulin receptor. A brute force approach based on 'substrate-trapping'
RT   mutants.";
RL   J. Biol. Chem. 275:9792-9796(2000).
RN   [12]
RP   FUNCTION IN DEPHOSPHORYLATION OF STAT3(ISOFORM 2).
RX   PubMed=12359225; DOI=10.1016/S0006-291X(02)02291-X;
RA   Yamamoto T., Sekine Y., Kashima K., Kubota A., Sato N., Aoki N.,
RA   Matsuda T.;
RT   "The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates
RT   interleukin-6-mediated signaling pathway through STAT3
RT   dephosphorylation.";
RL   Biochem. Biophys. Res. Commun. 297:811-817(2002).
RN   [13]
RP   FUNCTION IN DEPHOSPHORYLATION OF JAK1 AND JAK3, AND INTERACTION WITH
RP   JAK1 AND JAK3.
RX   PubMed=11909529; DOI=10.1016/S0960-9822(02)00697-8;
RA   Simoncic P.D., Lee-Loy A., Barber D.L., Tremblay M.L., McGlade C.J.;
RT   "The T cell protein tyrosine phosphatase is a negative regulator of
RT   janus family kinases 1 and 3.";
RL   Curr. Biol. 12:446-453(2002).
RN   [14]
RP   FUNCTION IN DEPHOSPHORYLATION OF STAT1.
RX   PubMed=12138178; DOI=10.1128/MCB.22.16.5662-5668.2002;
RA   ten Hoeve J., de Jesus Ibarra-Sanchez M., Fu Y., Zhu W., Tremblay M.,
RA   David M., Shuai K.;
RT   "Identification of a nuclear Stat1 protein tyrosine phosphatase.";
RL   Mol. Cell. Biol. 22:5662-5668(2002).
RN   [15]
RP   FUNCTION IN DEPHOSPHORYLATION OF INSR, MUTAGENESIS OF ASP-182, AND
RP   SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=12612081; DOI=10.1128/MCB.23.6.2096-2108.2003;
RA   Galic S., Klingler-Hoffmann M., Fodero-Tavoletti M.T., Puryer M.A.,
RA   Meng T.C., Tonks N.K., Tiganis T.;
RT   "Regulation of insulin receptor signaling by the protein tyrosine
RT   phosphatase TCPTP.";
RL   Mol. Cell. Biol. 23:2096-2108(2003).
RN   [16]
RP   PHOSPHORYLATION AT SER-304 BY CDK1 AND CDK2 (ISOFORM 2), AND
RP   MUTAGENESIS OF SER-304.
RX   PubMed=15030318; DOI=10.1042/BJ20031780;
RA   Bukczynska P., Klingler-Hoffmann M., Mitchelhill K.I., Lam M.H.,
RA   Ciccomancini M., Tonks N.K., Sarcevic B., Kemp B.E., Tiganis T.;
RT   "The T-cell protein tyrosine phosphatase is phosphorylated on Ser-304
RT   by cyclin-dependent protein kinases in mitosis.";
RL   Biochem. J. 380:939-949(2004).
RN   [17]
RP   FUNCTION IN DEPHOSPHORYLATION OF PDGFRB.
RX   PubMed=14966296; DOI=10.1128/MCB.24.5.2190-2201.2004;
RA   Persson C., Saevenhed C., Bourdeau A., Tremblay M.L., Markova B.,
RA   Boehmer F.D., Haj F.G., Neel B.G., Elson A., Heldin C.H.,
RA   Roennstrand L., Ostman A., Hellberg C.;
RT   "Site-selective regulation of platelet-derived growth factor beta
RT   receptor tyrosine phosphorylation by T-cell protein tyrosine
RT   phosphatase.";
RL   Mol. Cell. Biol. 24:2190-2201(2004).
RN   [18]
RP   INTERACTION WITH RMDN3.
RX   PubMed=15609043; DOI=10.1007/s00418-004-0732-7;
RA   Stenzinger A., Kajosch T., Tag C., Porsche A., Welte I., Hofer H.W.,
RA   Steger K., Wimmer M.;
RT   "The novel protein PTPIP51 exhibits tissue- and cell-specific
RT   expression.";
RL   Histochem. Cell Biol. 123:19-28(2005).
RN   [19]
RP   FUNCTION IN DEPHOSPHORYLATION OF EGFR, INTERACTION WITH ITGA1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15592458; DOI=10.1038/ncb1209;
RA   Mattila E., Pellinen T., Nevo J., Vuoriluoto K., Arjonen A.,
RA   Ivaska J.;
RT   "Negative regulation of EGFR signalling through integrin-alpha1beta1-
RT   mediated activation of protein tyrosine phosphatase TCPTP.";
RL   Nat. Cell Biol. 7:78-85(2005).
RN   [20]
RP   INTERACTION WITH TRAF2.
RX   PubMed=15696169; DOI=10.1038/ni1169;
RA   van Vliet C., Bukczynska P.E., Puryer M.A., Sadek C.M., Shields B.J.,
RA   Tremblay M.L., Tiganis T.;
RT   "Selective regulation of tumor necrosis factor-induced Erk signaling
RT   by Src family kinases and the T cell protein tyrosine phosphatase.";
RL   Nat. Immunol. 6:253-260(2005).
RN   [21]
RP   PHOSPHORYLATION BY PKR.
RX   PubMed=16431927; DOI=10.1074/jbc.M504977200;
RA   Wang S., Raven J.F., Baltzis D., Kazemi S., Brunet D.V., Hatzoglou M.,
RA   Tremblay M.L., Koromilas A.E.;
RT   "The catalytic activity of the eukaryotic initiation factor-2alpha
RT   kinase PKR is required to negatively regulate Stat1 and Stat3 via
RT   activation of the T-cell protein-tyrosine phosphatase.";
RL   J. Biol. Chem. 281:9439-9449(2006).
RN   [22]
RP   INTERACTION WITH TMED9.
RX   PubMed=16595549; DOI=10.1242/jcs.02885;
RA   Gupta V., Swarup G.;
RT   "Evidence for a role of transmembrane protein p25 in localization of
RT   protein tyrosine phosphatase TC48 to the ER.";
RL   J. Cell Sci. 119:1703-1714(2006).
RN   [23]
RP   FUNCTION IN DEPHOSPHORYLATION OF STAT6 (ISOFORM 2), AND INDUCTION BY
RP   IL4.
RX   PubMed=17210636; DOI=10.1128/MCB.01234-06;
RA   Lu X., Chen J., Sasmono R.T., Hsi E.D., Sarosiek K.A., Tiganis T.,
RA   Lossos I.S.;
RT   "T-cell protein tyrosine phosphatase, distinctively expressed in
RT   activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear
RT   phosphatase of STAT6.";
RL   Mol. Cell. Biol. 27:2166-2179(2007).
RN   [24]
RP   FUNCTION IN DEPHOSPHORYLATION OF MET, AND INTERACTION WITH MET.
RX   PubMed=18819921; DOI=10.1074/jbc.M805916200;
RA   Sangwan V., Paliouras G.N., Abella J.V., Dube N., Monast A.,
RA   Tremblay M.L., Park M.;
RT   "Regulation of the Met receptor-tyrosine kinase by the protein-
RT   tyrosine phosphatase 1B and T-cell phosphatase.";
RL   J. Biol. Chem. 283:34374-34383(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 AND SER-304, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   FUNCTION IN DEPHOSPHORYLATION OF LCK AND FYN.
RX   PubMed=22080863; DOI=10.1172/JCI59492;
RA   Wiede F., Shields B.J., Chew S.H., Kyparissoudis K., van Vliet C.,
RA   Galic S., Tremblay M.L., Russell S.M., Godfrey D.I., Tiganis T.;
RT   "T cell protein tyrosine phosphatase attenuates T cell signaling to
RT   maintain tolerance in mice.";
RL   J. Clin. Invest. 121:4758-4774(2011).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [30]
RP   INTERACTION WITH STX17, AND SUBCELLULAR LOCATION.
RX   PubMed=23006999; DOI=10.1016/j.bbamcr.2012.09.003;
RA   Muppirala M., Gupta V., Swarup G.;
RT   "Tyrosine phosphorylation of a SNARE protein, Syntaxin 17:
RT   Implications for membrane trafficking in the early secretory
RT   pathway.";
RL   Biochim. Biophys. Acta 1823:2109-2119(2012).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-298 AND
RP   SER-304, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298 AND SER-304, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.56 ANGSTROMS) OF 1-314, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11907034; DOI=10.1074/jbc.M200567200;
RA   Iversen L.F., Moller K.B., Pedersen A.K., Peters G.H., Petersen A.S.,
RA   Andersen H.S., Branner S., Mortensen S.B., Moller N.P.;
RT   "Structure determination of T cell protein-tyrosine phosphatase.";
RL   J. Biol. Chem. 277:19982-19990(2002).
CC   -!- FUNCTION: Non-receptor type tyrosine-specific phosphatase that
CC       dephosphorylates receptor protein tyrosine kinases including INSR,
CC       EGFR, CSF1R, PDGFR. Also dephosphorylates non-receptor protein
CC       tyrosine kinases like JAK1, JAK2, JAK3, Src family kinases, STAT1,
CC       STAT3, STAT5A, STAT5B and STAT6 either in the nucleus or the
CC       cytoplasm. Negatively regulates numerous signaling pathways and
CC       biological processes like hematopoiesis, inflammatory response,
CC       cell proliferation and differentiation, and glucose homeostasis.
CC       Plays a multifaceted and important role in the development of the
CC       immune system. Functions in T-cell receptor signaling through
CC       dephosphorylation of FYN and LCK to control T-cells
CC       differentiation and activation. Dephosphorylates CSF1R, negatively
CC       regulating its downstream signaling and macrophage
CC       differentiation. Negatively regulates cytokine (IL2/interleukin-2
CC       and interferon)-mediated signaling through dephosphorylation of
CC       the cytoplasmic kinases JAK1, JAK3 and their substrate STAT1, that
CC       propagate signaling downstream of the cytokine receptors. Also
CC       regulates the IL6/interleukin-6 and IL4/interleukin-4 cytokine
CC       signaling through dephosphorylation of STAT3 and STAT6
CC       respectively. In addition to the immune system, it is involved in
CC       anchorage-dependent, negative regulation of EGF-stimulated cell
CC       growth. Activated by the integrin ITGA1/ITGB1, it dephosphorylates
CC       EGFR and negatively regulates EGF signaling. Dephosphorylates
CC       PDGFRB and negatively regulates platelet-derived growth factor
CC       receptor-beta signaling pathway and therefore cell proliferation.
CC       Negatively regulates tumor necrosis factor-mediated signaling
CC       downstream via MAPK through SRC dephosphorylation. May also
CC       regulate the hepatocyte growth factor receptor signaling pathway
CC       through dephosphorylation of the hepatocyte growth factor receptor
CC       MET. Plays also an important role in glucose homeostasis. For
CC       instance, negatively regulates the insulin receptor signaling
CC       pathway through the dephosphorylation of INSR and control
CC       gluconeogenesis and liver glucose production through negative
CC       regulation of the IL6 signaling pathways. Finally, it negatively
CC       regulates prolactin-mediated signaling pathway through
CC       dephosphorylation of STAT5A and STAT5B. May also bind DNA.
CC       {ECO:0000269|PubMed:10734133, ECO:0000269|PubMed:11909529,
CC       ECO:0000269|PubMed:12138178, ECO:0000269|PubMed:12612081,
CC       ECO:0000269|PubMed:14966296, ECO:0000269|PubMed:15592458,
CC       ECO:0000269|PubMed:18819921, ECO:0000269|PubMed:22080863,
CC       ECO:0000269|PubMed:9488479}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.48 mM for p-nitrophenyl phosphate (at pH 6.5 and 25 degrees
CC         Celsius) {ECO:0000269|PubMed:11907034};
CC   -!- SUBUNIT: Interacts with RMDN3. Isoform 1 interacts with TMED9.
CC       Isoform 1 interacts with STX17; dephosphorylates STX17. Interacts
CC       with ITGA1 (via cytoplasmic domain); activates the phosphatase
CC       activity towards EGFR. Interacts with TRAF2; probably involved in
CC       tumor necrosis factor-mediated signaling. Interacts with MET.
CC       {ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:15592458,
CC       ECO:0000269|PubMed:15609043, ECO:0000269|PubMed:15696169,
CC       ECO:0000269|PubMed:16595549, ECO:0000269|PubMed:18819921,
CC       ECO:0000269|PubMed:23006999}.
CC   -!- INTERACTION:
CC       P10912:GHR; NbExp=8; IntAct=EBI-984930, EBI-286316;
CC       P49755:TMED10; NbExp=5; IntAct=EBI-4409481, EBI-998422;
CC       Q9BVK6:TMED9; NbExp=5; IntAct=EBI-4409481, EBI-1056827;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:7593185}. Endoplasmic reticulum-Golgi
CC       intermediate compartment {ECO:0000269|PubMed:7593185}.
CC       Note=Targeted to the endoplasmic reticulum by its C-terminal
CC       hydrophobic region. {ECO:0000269|PubMed:7593185}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Nucleus. Cytoplasm. Cell
CC       membrane. Note=Predominantly localizes to chromatin (By
CC       similarity). Able to shuttle between the nucleus and the cytoplasm
CC       and to dephosphorylate plasma membrane receptors (PubMed:9488479).
CC       Recruited by activated ITGA1 at the plasma membrane. {ECO:0000250,
CC       ECO:0000269|PubMed:9488479}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PTPB, p48TC, TC48, TC-PTPb;
CC         IsoId=P17706-1; Sequence=Displayed;
CC         Note=Minor isoform.;
CC       Name=2; Synonyms=PTPA, p45TC, TC45, TC-PTPa;
CC         IsoId=P17706-2; Sequence=VSP_005125;
CC         Note=Major isoform. Contains a phosphoserine at position 304.
CC         Contains a nuclear location signal at positions 377-381
CC         (PubMed:7593185) and an autoinhibitory region acting through
CC         intramolecular interactions is found at positions 353-387.
CC         {ECO:0000269|PubMed:15030318, ECO:0000305|PubMed:7593185};
CC       Name=3;
CC         IsoId=P17706-3; Sequence=VSP_043383, VSP_005125;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P17706-4; Sequence=VSP_054821, VSP_005125;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on cDNA data.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is probably
CC       the major isoform. Isoform 1 is expressed in T-cells and in
CC       placenta. {ECO:0000269|PubMed:1731319,
CC       ECO:0000269|PubMed:2546150}.
CC   -!- INDUCTION: Up-regulated by IL4/interleukin-4 (at protein level).
CC       {ECO:0000269|PubMed:17210636}.
CC   -!- PTM: Isoform 2: Specifically phosphorylated in a cell cycle-
CC       dependent manner by cyclin-dependent kinases CDK1 and CDK2.
CC       Probably activated through phosphorylation by PKR.
CC       {ECO:0000269|PubMed:15030318, ECO:0000269|PubMed:16431927}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class 1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M25393; AAA65997.1; -; mRNA.
DR   EMBL; AK292570; BAF85259.1; -; mRNA.
DR   EMBL; EF445017; ACA06062.1; -; Genomic_DNA.
DR   EMBL; EF445017; ACA06064.1; -; Genomic_DNA.
DR   EMBL; AP001077; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005482; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471113; EAX01532.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01539.1; -; Genomic_DNA.
DR   EMBL; BC008244; AAH08244.1; -; mRNA.
DR   EMBL; BC016727; AAH16727.1; -; mRNA.
DR   EMBL; M81478; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS11863.1; -. [P17706-2]
DR   CCDS; CCDS11864.1; -. [P17706-3]
DR   CCDS; CCDS11865.1; -. [P17706-1]
DR   CCDS; CCDS59306.1; -. [P17706-4]
DR   PIR; A33899; A33899.
DR   RefSeq; NP_001193942.1; NM_001207013.1. [P17706-4]
DR   RefSeq; NP_002819.2; NM_002828.3. [P17706-1]
DR   RefSeq; NP_536347.1; NM_080422.2. [P17706-2]
DR   RefSeq; NP_536348.1; NM_080423.2. [P17706-3]
DR   UniGene; Hs.654527; -.
DR   UniGene; Hs.663373; -.
DR   PDB; 1L8K; X-ray; 2.56 A; A=1-314.
DR   PDBsum; 1L8K; -.
DR   ProteinModelPortal; P17706; -.
DR   SMR; P17706; -.
DR   BioGrid; 111737; 27.
DR   IntAct; P17706; 19.
DR   MINT; MINT-3975566; -.
DR   STRING; 9606.ENSP00000311857; -.
DR   BindingDB; P17706; -.
DR   ChEMBL; CHEMBL3807; -.
DR   DEPOD; P17706; -.
DR   iPTMnet; P17706; -.
DR   PhosphoSitePlus; P17706; -.
DR   BioMuta; PTPN2; -.
DR   DMDM; 229462762; -.
DR   EPD; P17706; -.
DR   MaxQB; P17706; -.
DR   PaxDb; P17706; -.
DR   PeptideAtlas; P17706; -.
DR   PRIDE; P17706; -.
DR   DNASU; 5771; -.
DR   Ensembl; ENST00000309660; ENSP00000311857; ENSG00000175354. [P17706-1]
DR   Ensembl; ENST00000327283; ENSP00000320298; ENSG00000175354. [P17706-2]
DR   Ensembl; ENST00000353319; ENSP00000320546; ENSG00000175354. [P17706-3]
DR   Ensembl; ENST00000591115; ENSP00000466936; ENSG00000175354. [P17706-4]
DR   GeneID; 5771; -.
DR   KEGG; hsa:5771; -.
DR   UCSC; uc002krl.4; human. [P17706-1]
DR   CTD; 5771; -.
DR   DisGeNET; 5771; -.
DR   GeneCards; PTPN2; -.
DR   HGNC; HGNC:9650; PTPN2.
DR   HPA; HPA015004; -.
DR   HPA; HPA046176; -.
DR   MalaCards; PTPN2; -.
DR   MIM; 176887; gene.
DR   neXtProt; NX_P17706; -.
DR   OpenTargets; ENSG00000175354; -.
DR   Orphanet; 206; Crohn disease.
DR   Orphanet; 85408; Juvenile rheumatoid factor-negative polyarthritis.
DR   Orphanet; 85410; Oligoarticular juvenile arthritis.
DR   Orphanet; 771; Ulcerative colitis.
DR   PharmGKB; PA33993; -.
DR   eggNOG; KOG0789; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136380; -.
DR   HOGENOM; HOG000273908; -.
DR   HOVERGEN; HBG008321; -.
DR   InParanoid; P17706; -.
DR   KO; K18026; -.
DR   OMA; WQQLYLE; -.
DR   OrthoDB; EOG091G082B; -.
DR   PhylomeDB; P17706; -.
DR   TreeFam; TF315897; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-877312; Regulation of IFNG signaling.
DR   SignaLink; P17706; -.
DR   SIGNOR; P17706; -.
DR   ChiTaRS; PTPN2; human.
DR   EvolutionaryTrace; P17706; -.
DR   GeneWiki; PTPN2; -.
DR   GenomeRNAi; 5771; -.
DR   PRO; PR:P17706; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000175354; -.
DR   CleanEx; HS_PTPN2; -.
DR   ExpressionAtlas; P17706; baseline and differential.
DR   Genevisible; P17706; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0097677; F:STAT family protein binding; IEA:Ensembl.
DR   GO; GO:0019905; F:syntaxin binding; IPI:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0050922; P:negative regulation of chemotaxis; ISS:UniProtKB.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902206; P:negative regulation of interleukin-2-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:1902215; P:negative regulation of interleukin-4-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0070104; P:negative regulation of interleukin-6-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0010888; P:negative regulation of lipid storage; ISS:UniProtKB.
DR   GO; GO:1902227; P:negative regulation of macrophage colony-stimulating factor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045650; P:negative regulation of macrophage differentiation; ISS:UniProtKB.
DR   GO; GO:2000587; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902233; P:negative regulation of positive thymic T cell selection; ISS:UniProtKB.
DR   GO; GO:1902212; P:negative regulation of prolactin signaling pathway; ISS:UniProtKB.
DR   GO; GO:0061099; P:negative regulation of protein tyrosine kinase activity; IEA:Ensembl.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0042512; P:negative regulation of tyrosine phosphorylation of Stat1 protein; IMP:UniProtKB.
DR   GO; GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; IDA:UniProtKB.
DR   GO; GO:0042524; P:negative regulation of tyrosine phosphorylation of Stat5 protein; ISS:UniProtKB.
DR   GO; GO:0042527; P:negative regulation of tyrosine phosphorylation of Stat6 protein; IMP:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:1902237; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0045722; P:positive regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:1903899; P:positive regulation of PERK-mediated unfolded protein response; IEA:Ensembl.
DR   GO; GO:1902202; P:regulation of hepatocyte growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030217; P:T cell differentiation; ISS:UniProtKB.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR012265; Ptpn1/Ptpn2.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000926; Tyr-Ptase_nr1; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; Endoplasmic reticulum; Hydrolase; Membrane; Nucleus;
KW   Phosphoprotein; Protein phosphatase; Reference proteome.
FT   CHAIN         1    415       Tyrosine-protein phosphatase non-receptor
FT                                type 2.
FT                                /FTId=PRO_0000094752.
FT   DOMAIN        5    275       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION      216    222       Substrate binding. {ECO:0000250}.
FT   REGION      346    415       Endoplasmic reticulum location.
FT   REGION      376    415       Mediates interaction with STX17.
FT                                {ECO:0000269|PubMed:23006999}.
FT   ACT_SITE    216    216       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING     182    182       Substrate. {ECO:0000250}.
FT   BINDING     260    260       Substrate. {ECO:0000250}.
FT   MOD_RES     293    293       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     298    298       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     165    165       N -> NYIENLWITLYLKLLMLDVKRSLK (in isoform
FT                                4). {ECO:0000305}.
FT                                /FTId=VSP_054821.
FT   VAR_SEQ     347    380       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043383.
FT   VAR_SEQ     382    415       WLYWQPILTKMGFMSVILVGAFVGWTLFFQQNAL -> PRL
FT                                TDT (in isoform 2, isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1731319}.
FT                                /FTId=VSP_005125.
FT   MUTAGEN     182    182       D->A: Substrate-trapping mutant;
FT                                catalytically inactive it forms a stable
FT                                complex with physiological substrates
FT                                including INSR and EGFR. Accumulates in
FT                                the cytoplasm upon stimulation by insulin
FT                                or EGF; isoform 2.
FT                                {ECO:0000269|PubMed:12612081,
FT                                ECO:0000269|PubMed:9488479}.
FT   MUTAGEN     222    222       R->M: Impairs phosphatase activity.
FT   MUTAGEN     304    304       S->A: Alters phosphorylation by cyclin-
FT                                dependent kinases of isoform 2 but has no
FT                                effect on its phosphatase activity.
FT                                {ECO:0000269|PubMed:15030318}.
FT   MUTAGEN     350    352       RKR->QQQ: Alters location to the
FT                                endoplasmic reticulum; isoform 1.
FT                                {ECO:0000269|PubMed:7593185}.
FT   MUTAGEN     380    380       K->Q: Prevents location to the nucleus;
FT                                isoform 2. {ECO:0000269|PubMed:7593185}.
FT   CONFLICT    407    407       T -> R (in Ref. 1; AAA65997 and 7;
FT                                M81478). {ECO:0000305}.
FT   HELIX         7     14       {ECO:0000244|PDB:1L8K}.
FT   HELIX        19     28       {ECO:0000244|PDB:1L8K}.
FT   HELIX        35     38       {ECO:0000244|PDB:1L8K}.
FT   HELIX        40     45       {ECO:0000244|PDB:1L8K}.
FT   TURN         55     57       {ECO:0000244|PDB:1L8K}.
FT   STRAND       58     60       {ECO:0000244|PDB:1L8K}.
FT   STRAND       68     76       {ECO:0000244|PDB:1L8K}.
FT   HELIX        77     79       {ECO:0000244|PDB:1L8K}.
FT   STRAND       81     87       {ECO:0000244|PDB:1L8K}.
FT   TURN         91     93       {ECO:0000244|PDB:1L8K}.
FT   HELIX        94    103       {ECO:0000244|PDB:1L8K}.
FT   STRAND      108    111       {ECO:0000244|PDB:1L8K}.
FT   STRAND      129    132       {ECO:0000244|PDB:1L8K}.
FT   STRAND      134    136       {ECO:0000244|PDB:1L8K}.
FT   TURN        137    140       {ECO:0000244|PDB:1L8K}.
FT   STRAND      141    150       {ECO:0000244|PDB:1L8K}.
FT   STRAND      152    163       {ECO:0000244|PDB:1L8K}.
FT   TURN        164    166       {ECO:0000244|PDB:1L8K}.
FT   STRAND      169    177       {ECO:0000244|PDB:1L8K}.
FT   STRAND      182    184       {ECO:0000244|PDB:1L8K}.
FT   HELIX       190    201       {ECO:0000244|PDB:1L8K}.
FT   TURN        202    205       {ECO:0000244|PDB:1L8K}.
FT   STRAND      212    221       {ECO:0000244|PDB:1L8K}.
FT   HELIX       222    235       {ECO:0000244|PDB:1L8K}.
FT   STRAND      236    239       {ECO:0000244|PDB:1L8K}.
FT   HELIX       244    251       {ECO:0000244|PDB:1L8K}.
FT   TURN        252    254       {ECO:0000244|PDB:1L8K}.
FT   HELIX       262    275       {ECO:0000244|PDB:1L8K}.
SQ   SEQUENCE   415 AA;  48473 MW;  0207694A4F058E68 CRC64;
     MPTTIEREFE ELDTQRRWQP LYLEIRNESH DYPHRVAKFP ENRNRNRYRD VSPYDHSRVK
     LQNAENDYIN ASLVDIEEAQ RSYILTQGPL PNTCCHFWLM VWQQKTKAVV MLNRIVEKES
     VKCAQYWPTD DQEMLFKETG FSVKLLSEDV KSYYTVHLLQ LENINSGETR TISHFHYTTW
     PDFGVPESPA SFLNFLFKVR ESGSLNPDHG PAVIHCSAGI GRSGTFSLVD TCLVLMEKGD
     DINIKQVLLN MRKYRMGLIQ TPDQLRFSYM AIIEGAKCIK GDSSIQKRWK ELSKEDLSPA
     FDHSPNKIMT EKYNGNRIGL EEEKLTGDRC TGLSSKMQDT MEENSESALR KRIREDRKAT
     TAQKVQQMKQ RLNENERKRK RWLYWQPILT KMGFMSVILV GAFVGWTLFF QQNAL
//
